Kaufman 2012 Descendants Trust, David N. Smith, Trustee

Kaufman 2012 Descendants Trust sold 22,692 shares of AGYS for $2,192,500.20 across 3 days, blended avg $96.62; stock now $92.24, -34.9% from 52-week high.

Kaufman 2012 Descendants Trust, David N. Smith, Trustee executed 3 separate sales totaling 22,692 shares (22.7K shares) for $2,192,500.20 ($2.2M) on January 22–24, 2025, with a blended average price of $96.62. The transactions occurred as the stock was already declining sharply: AGYS is now trading at $92.24, down 34.9% from its 52-week high of $141.74 and down 33.6% over the prior 30 days. The insider reduced holdings by 9.1% to 225,384 shares (225.4K shares). This filing represents multiple liquidation transactions executed within a narrow window while the stock was under significant downward pressure. The $2.6B market cap company carries a notably elevated P/E of 115.30 despite 19.9% annual revenue growth, and the timing of these sales during a steep drawdown—coupled with the recent frequency of same-ticker sales (5 prior trades between January 14–21)—warrants investor attention to the underlying business fundamentals and any associated drivers of the stock's sharp contraction.

Kaufman Trust (David N. Smith, Trustee) sells 22,500 AGYS shares in 3 transactions (Jan 16–21) for $2,905,275 at avg $129.12; retains 248.1K shares.

Kaufman 2012 Descendants Trust completed three separate sales totaling 22,500 shares for $2,905,275.00 between January 16 and January 21, 2025, with a blended average price of $129.12. The trust sold during a period when AGYS stock was down 9.2% over the prior 30 days and -11.2% from its 52-week high of $141.74, though up 15.8% over 90 days. The seller retains substantial holdings (248.1K shares, down 8.3% from pre-transaction), indicating this is a partial position reduction rather than an exit. The timing follows a pattern of six consecutive daily sales (January 8, 10, 13, 14, 15, and the three reported sales on 16–21), suggesting systematic liquidation rather than a single opportunistic trade. With a P/E of 157.38 and the stock trading near its 52-week high range, this activity occurs in a period of elevated valuation metrics.

Kaufman 2012 Descendants Trust sold 22,500 AGYS shares (22.5K) for $2,910,375.00 over 3 days; holdings fall to 270.6K shares post-sale

The Kaufman 2012 Descendants Trust, via David N. Smith as Trustee, executed 3 separate sales totaling 22,500 shares for $2,910,375.00 ($2.9M) at prices ranging from $126.26 to $132.98 (blended average $129.35) over January 13–15, 2025. The sale reduces holdings from 293.1K to 270.6K shares, a -7.7% reduction. The trust's 5 prior open-market sales at AGYS (January 3–10) show a consistent pattern of liquidation activity; outcomes from those earlier trades are not yet measurable at the 90-day mark. At current price of $132.75, the stock trades -6.3% from its 52-week high of $141.74 and is up 6.5% over 90 days, though down 4.6% in the last 30 days. The company's P/E of 38.82 and annual revenue growth of 19.9% suggest a high-valuation, growth-stage profile. This filing reflects sustained discretionary reduction of a large equity stake without disclosed rationale.

Kaufman Trust (David N. Smith, Trustee) sold 22,500 AGYS shares for $2,931,750.00 across three days at blended avg $130.30

The Kaufman 2012 Descendants Trust sold 22,500 shares (22.5K shares) for $2,931,750.00 through 3 separate sales on January 7, 8, and 10, 2025 at prices ranging from $128.57 to $132.04, reducing holdings from 315,576 to 293,076 shares. The transaction occurred near the stock's 52-week high of $141.74 (current price of $128.08 is -9.6% from that peak), and follows a pattern of sales activity—the insider completed 3 prior trades at AGYS on January 2, 3, and 6. The stock has risen 11.5% over 90 days and the trust retains 293,076 shares (293.1K shares) post-transaction, indicating a partial reduction rather than full exit. Given the trust structure and absence of any disclosed scheduled plan, the timing and phased execution merit monitoring for any broader positioning shifts.

Kaufman 2012 Descendants Trust sold 22,500 AGYS shares for $2,951,625.00 across 3 transactions (Jan 2–6), retaining 315,576 shares.

The Kaufman 2012 Descendants Trust, through trustee David N. Smith, executed 3 separate sales totaling 22,500 shares for $2,951,625.00 between January 2–6, 2025, at a blended average price of $131.18, near current price of $130.15. The trust retains 315,576 shares post-transaction, representing a -6.7% reduction in holdings. AGYS has rallied +19.6% over 90 days despite being -8.2% from its 52-week high of $141.74, and carries a high P/E of 38.06 relative to modest quarterly net income of $1,364,000.00. Without a FLAG section indicating a scheduled 10b5-1 plan, the timing of these three consecutive open-market sales at prices near the current level provides limited information about the trustee's forward view; the transaction data alone does not distinguish between estate management, portfolio rebalancing, or other motives.